Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. Diosmectite
Diosmectite
From Wikipedia, the free encyclopedia
Silicate of aluminium and magnesium
Pharmaceutical compound
Diosmectite
Diosmectite powder
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
  • A07BC05 (WHO)
Identifiers
CAS Number
  • 1318-93-0 ☒N
UNII
  • A585MN1H2L
Chemical and physical data
Formula(Na-Ca)0.33-(Al-Mg)2-Si4-O10-(O-H)2·(H2O)2
 ☒NcheckY (what is this?)  (verify)

Diosmectite (brand names Smecta, Smecdral) is a natural silicate of aluminium and magnesium used as an intestinal adsorbent in the treatment of several gastrointestinal diseases, including infectious and non-infectious acute and chronic diarrhoea, including irritable bowel syndrome diarrhea subtype. Other uses include: chronic diarrhea caused by radiation-induced, chemotherapy-induced, and HIV/AIDS-associated chronic diarrhea.[1]

It is insoluble in water. It is usually taken orally as a suspension in warm water. In the field of geology, it is more commonly known as montmorillonite. Diosmectite is a contraction of "dioctahedral smectite".

Mechanism of action

[edit]

Its effectiveness in improving stool consistency is the result of its alleged ability to absorb bacteria, viruses and toxins as well as strengthening the intestinal mucus barrier to reduce luminal antigens passing through the mucus barrier which in turn helps to reduce inflammation.[1]

Diosmectite may be a useful additive in the treatment of acute childhood diarrhoea. As evidence is of ‘low quality’, future research is needed with higher quality designs before any firm recommendations can be made.[2]

See also

[edit]
  • Geophagy
  • Medicinal clay

References

[edit]
  1. ^ a b Lee KJ (October 2015). "Pharmacologic Agents for Chronic Diarrhea". Intestinal Research. 13 (4): 306–312. doi:10.5217/ir.2015.13.4.306. PMC 4641856. PMID 26576135.
  2. ^ Das RR, Sankar J, Naik SS (July 2015). "Efficacy and safety of diosmectite in acute childhood diarrhoea: a meta-analysis". Archives of Disease in Childhood. 100 (7): 704–712. doi:10.1136/archdischild-2014-307632. PMID 25784748. S2CID 20092600.

Further reading

[edit]
  • Santantonio M, Colella M, Fiorica F, Pratissoli S, Stefanelli A, Falchi AM, et al. (December 2000). "Diosmectite (DIOSMECTAL) in preventive anti-diarrheic therapy in patients subjected to pelvic radiation". Minerva Gastroenterologica e Dietologica. 46 (4): 225–230. PMID 16501441.
  • v
  • t
  • e
Antidiarrheals, intestinal anti-inflammatory and anti-infective agents (A07)
Rehydration
  • Oral rehydration therapy
Intestinal anti-infectives
  • Antibiotics
    • Amphotericin B
    • Colistin
    • Fidaxomicin
    • Kanamycin
    • Natamycin
    • Neomycin
    • Nystatin
    • Paromomycin
    • Polymyxin B
    • Rifaximin
    • Streptomycin
    • Vancomycin
  • Sulfonamides
    • Phthalylsulfathiazole
    • Succinylsulfathiazole
    • Sulfaguanidine
  • Nitrofuran
    • Nifuroxazide
    • Nifurzide
  • Imidazole
    • Miconazole
  • Arsenical
    • Acetarsol
  • Oxyquinoline
    • Broxyquinoline
Intestinal adsorbents
  • Charcoal
  • Bismuth (including bismuth subsalicylate, known as Pepto-Bismol)
  • Pectin
  • Kaolin
  • Crospovidone
  • Attapulgite
  • Diosmectite
Antipropulsives (opioids)
  • Opium tincture (laudanum)
  • Codeine
  • Morphine
  • Camphorated opium tincture (paregoric)
  • crosses BBB: Diphenoxylate (+atropine)
  • Difenoxin
  • does not cross BBB: Eluxadoline
  • Loperamide# (+simethicone)
Intestinal anti-inflammatory agents
  • corticosteroids acting locally
    • Prednisolone#
    • Hydrocortisone
    • Prednisone
    • Betamethasone#
    • Tixocortol
    • Budesonide
    • Beclometasone
  • antiallergic agents, excluding corticosteroids
    • Cromoglicic acid
  • Aminosalicylates
    • Sulfasalazine
    • Mesalazine
    • Olsalazine
    • Balsalazide
Antidiarrheal micro-organisms
  • Escherichia coli
  • Saccharomyces boulardii
Other antidiarrheals
  • Albumin tannate
  • Bismuth subsalicylate
  • Ceratonia
  • Crofelemer
  • Octreotide
  • Racecadotril
  • Kaopectate
  • #WHO-EM
  • ‡Withdrawn from market
  • Clinical trials:
    • †Phase III
    • §Never to phase III
Retrieved from "https://en.wikipedia.org/w/index.php?title=Diosmectite&oldid=1327196783"
Categories:
  • Digestive system
  • Medicinal clay
Hidden categories:
  • Articles with short description
  • Short description is different from Wikidata
  • Articles with changed CASNo identifier
  • Articles without EBI source
  • Chemical pages without ChemSpiderID
  • Chemical pages without DrugBank identifier
  • Articles without KEGG source
  • Articles without InChI source
  • Drugs with no legal status
  • Drugboxes which contain changes to verified fields

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id